Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of breast cancer using combination therapies comprising an AKT inhibitor, a taxane, and a PD-L1 inhibitor

Treatment of breast cancer using combination therapies comprising an AKT inhibitor, a taxane, and a PD-L1 inhibitor

US Patent 11701356 · Granted Jul 18, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Protease-activated contrast agents for in vivo imaging2025
Handover management in a communications network configured to support multi-rat 2025
Handover management in a communications network configured to support multi-RAT 2024
Protease-activated contrast agents for in vivo imaging2023
Protease-activated contrast agents for in vivo imaging2020
Control of gene expression in plants2014
Gene expression control in plants2014